Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients
2023 · BMC Cancer · 37 citations
https://doi.org/10.1186/s12885-023-10824-3
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
121
Papers
4.3K
Citations
32
h-index
61
i10-index
Katja Seipel is an academic researcher from University of Bern. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Multiple Myeloma Research and Treatments & CAR-T cell therapy research. The author has an h-index of 32, co-authored 103 publications.
ORCID: 0000-0003-3128-1573Click to start Chat